| Literature DB >> 36248370 |
Xinyu Wang1, Qing Wang1, Xindi Zhang1, Hang Yin1, Yujie Fu1, Min Cao1, Xiaojing Zhao1.
Abstract
Background: An increasing number of lung ground-glass nodules (GGNs) have been detected ever since low-dose computer tomography started growing in popularity. Three-dimensional (3D) reconstruction technology plays a critical role in lung resection, especially in segmentectomy. In this study, we explore the role of 3D reconstruction in thoracoscopic complex segmentectomy of lower lung lobe.Entities:
Keywords: 3D reconstruction; Japan Clinical Oncology Group (JCOG); complex segmentectomy; ground-glass nodules (GGN); lung cancer
Year: 2022 PMID: 36248370 PMCID: PMC9559829 DOI: 10.3389/fsurg.2022.968199
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Selection algorithm of patients in this study.
Figure 2Right S9 + 10 VATS segmentectomy under real-time 3D reconstruction guidance. (A) preoperative CT scan showing a 10 mm GGN lesion in the right S9 + 10. (B) Branches of the pulmonary artery, (C) branches of the bronchus, and (D) branches of the pulmonary vein of the target segment were compared by using the real-time guidance of 3D reconstruction.
Figure 3Left S9 VATS segmentectomy under real-time 3D reconstruction guidance (with the subsuperior segment S*). (A) preoperative CT scan showing a 6 mm GGN lesion in the left S9. (B) Branches of the pulmonary vein, (C) branches of the pulmonary artery, including A*, and (D) branches of the bronchus, including B*, compared by using the real-time guidance of 3D reconstruction.
The position and distribution of the complex segmentectomies of the lower lung.
| Surgery types | 3D group | Routine group |
|---|---|---|
| ( | ( | |
| Right lower lobe | 23 (54.8%) | 29 (52.7%) |
| S7 | 0 | 1 |
| S8 | 11 | 9 |
| S9 | 2 | 5 |
| S10 | 2 | 5 |
| S8 + 9 | 2 | 3 |
| S9 + 10 | 4 | 4 |
| Others | 2 | 2 |
| Left lower lobe | 19 (45.2%) | 26 (47.3%) |
| S8 | 6 | 6 |
| S9 | 3 | 1 |
| S10 | 4 | 10 |
| S8 + 9 | 2 | 3 |
| S9 + 10 | 2 | 5 |
| Others | 2 | 1 |
The demographics of patients and lung nodules in the 3D group and routine group.
| Values | 3D group | Routine group | |
|---|---|---|---|
| ( | ( | ||
| Age (years) | 55.3 ± 13.2 | 59.4 ± 13.9 | 0.14 |
| Sex | |||
| Male | 10 | 18 | 0.34 |
| Female | 32 | 37 | |
| Pulmonary function | |||
| FEV1 (%) | 83.7 ± 6.5 | 82.4 ± 7.7 | 0.38 |
| DLCO (%) | 79.2 ± 8.2 | 81.2 ± 10.0 | 0.31 |
| Nodule size on HRCT (mm) | 12.2 ± 4.4 | 12.8 ± 4.5 | 0.46 |
| CTR (%) | |||
| 0 ∼ 50 | 33 | 41 | 0.64 |
| 50 ∼ 100 | 9 | 14 | |
| BMI (kg/m2) | 23.1 ± 3.6 | 23.1 ± 3.0 | 0.93 |
| Surgical approach | |||
| Uniportal | 30 | 32 | 0.18 |
| Multiportal | 12 | 23 | |
| Histology type | 0.7 | ||
| Adenocarcinoma | 38 | 51 | |
| Squamous cell carcinoma | 2 | 1 | |
| Others | 2 | 3 | |
| Comorbidity | 0.78 | ||
| Hypertension | 10 | 9 | |
| Diabetes | 5 | 4 | |
| Coronary artery disease | 5 | 7 | |
CTR, consolidation-to-tumor ratio; HRCT, high-resolution computer tomography.
Perioperative outcomes of the 3D group and routine group.
| Values | 3D group | Routine group | |
|---|---|---|---|
| ( | ( | ||
| Operation time (min) | 111.4 ± 20.8 | 127.1 ± 32.3 | 0.007 |
| Intraoperative blood loss (ml) | 47.9 ± 29.1 | 51.1 ± 36.3 | 0.638 |
| Inadequate resection margins | 0 (0%) | 4 (7.3%) | 0.131 |
| Number of stapler reloads | 9.0 ± 2.2 | 10.4 ± 2.6 | 0.009 |
| Postoperative drainage (ml) | 488.7 ± 188.4 | 525.0 ± 229.3 | 0.407 |
| Postoperative hospital stay (days) | 4.6 ± 1.7 | 4.4 ± 1.7 | 0.521 |
| Postoperative complications | |||
| Air leakage on POD 1–3 | 5 (11.9%) | 17 (30.9%) | 0.027 |
| Pneumonia/atelectasis | 4 (9.5%) | 4 (7.3%) | 0.979 |
| Hemoptysis (>10 ml) | 2 (4.8%) | 4 (7.3%) | 0.934 |
Inadequate surgical margin: resection margin <2 cm or the diameter of the nodule.
POD, postoperative day.